Summit Creek Advisors buys $18,149,317 stake in Proto Labs Inc (PRLB)

Proto Labs Inc (PRLB) : Summit Creek Advisors scooped up 14,865 additional shares in Proto Labs Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 20, 2016. The investment management firm now holds a total of 222,691 shares of Proto Labs Inc which is valued at $18,149,317.Proto Labs Inc makes up approximately 2.80% of Summit Creek Advisors’s portfolio.

Proto Labs Inc opened for trading at $79.65 and hit $82.06 on the upside on Friday, eventually ending the session at $81.5, with a gain of 2.05% or 1.64 points. The heightened volatility saw the trading volume jump to 2,63,410 shares. Company has a market cap of $2,135 M.

Other Hedge Funds, Including , Gw&k Investment Management boosted its stake in PRLB in the latest quarter, The investment management firm added 31,416 additional shares and now holds a total of 663,152 shares of Proto Labs Inc which is valued at $54,046,888. Proto Labs Inc makes up approx 1.19% of Gw&k Investment Management’s portfolio. Integrated Investment Consultants added PRLB to its portfolio by purchasing 1,180 company shares during the most recent quarter which is valued at $92,618. Proto Labs Inc makes up approx 0.05% of Integrated Investment Consultants’s portfolio.Juncture Wealth Strategies reduced its stake in PRLB by selling 490 shares or 9.22% in the most recent quarter. The Hedge Fund company now holds 4,825 shares of PRLB which is valued at $378,714. Proto Labs Inc makes up approx 0.28% of Juncture Wealth Strategies’s portfolio.Capital Investment Services Of America reduced its stake in PRLB by selling 824 shares or 0.48% in the most recent quarter. The Hedge Fund company now holds 171,607 shares of PRLB which is valued at $13,048,996. Proto Labs Inc makes up approx 2.51% of Capital Investment Services Of America’s portfolio.

On the company’s financial health, Proto Labs Inc reported $0.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Feb 4, 2016. Analyst had a consensus of $0.47. The company had revenue of $73.80 million for the quarter, compared to analysts expectations of $71.77 million. The company’s revenue was up 31.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 EPS.

Proto Labs Inc. (Proto Labs) is an online manufacturer of custom parts for prototyping and short-run production. The Company utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts for its customers. The Company provides parts for product developers and engineers across the world. The Company utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts for its customers. The Company targets its products to the product developers and engineers who use three-dimensional computer-aided design (3D CAD) software to design products across a diverse range of end-markets. Its primary manufacturing product lines include Protomold which is an injection molding product line Firstcut which is a CNC machining product line and Fineline which is an additive-manufactured (3D printing) product line. The Company has operations in the United States Europe and Japan.

Leave a Reply

Proto Labs Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Proto Labs Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.